Researchers have developed a machine learning model called DreaMS, which significantly accelerates the analysis of previously unknown molecules. The study is published in Nature Biotechnology.

Rokeby brings a distinctive perspective to this exploration through his work as director of the University of Toronto’s BMO ...

UK biotech Nucleome Therapeutics has appointed Bhavna Hunjan as chief business officer, a move that strengthens its ...

Nucleome Therapeutics (‘Nucleome’ or ‘the Company’), a biotechnology company harnessing the power of non-coding human genetics to discover first-in-class antibody treatments for inflammatory diseases, ...

Biotechnology has emerged as a driving force in transforming healthcare. Over the past few decades, the integration of biology with advanced technology has led to significant breakthroughs. These ...

This year's winner of the Neuron Award for young promising scientists, Dr. Tomáš Pluskal from IOCB Prague, together with his student Roman Bushuiev ...

Frequency Electronics has been leading innovations in timing, navigation and quantum sensing for aerospace and defense. Read ...

No longer will our medicines be gated through animals, but rather through entirely human systems — leading to breakthrough ...

Fourth, talent will be the X-factor—biomanufacturing’s future turns on a specialised workforce trained at the intersection of ...

Antimicrobial-resistant (AMR) “superbugs” contribute to more than 4.5 million deaths globally per year and threaten to make ...

Medical robotics first entered general surgery in the 1980s with laparoscopic tools that enabled minimally invasive ...